New strategy to attack aggressive brain cancer shows promise
Time:2024-05-01 05:29:19 Source:healthViews(143)
WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
You may also like
- Alicia Keys, Brian d’Arcy James, Daniel Radcliffe and more react to earning Tony Award nominations
- Fish farm develops into tourist hotspot in exploration of modern aquaculture
- New Godzilla x Kong film tops Chinese box office
- Trump could avoid trial this year on 2020 election charges. Is the hush money case a worthy proxy?
- Alicia Keys, Brian d’Arcy James, Daniel Radcliffe and more react to earning Tony Award nominations
- Farmers reduce methane emissions by changing how they grow rice in Vietnam
- Defending Cup champion Vegas goes with Thompson in net for Game 1 in Dallas; Stone scores in return
- China, U.S. make preparations to send a pair of giant pandas to San Francisco Zoo in 2025
- Family appeals ruling that threw out lawsuit over 2017 BIA shooting death in North Dakota